| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| HumanPheno | Hypoplasia of the maxilla | 2.22e-05 | 130 | 35 | 7 | HP:0000327 | |
| HumanPheno | Aplasia/Hypoplasia of the maxilla | 2.58e-05 | 133 | 35 | 7 | HP:0009117 | |
| MousePheno | decreased body length | BMP2 MFSD2A NEK1 USP42 RPS6KA3 PLXNA4 AUTS2 RREB1 CDH11 UNC80 SON | 1.90e-06 | 484 | 54 | 11 | MP:0001258 |
| MousePheno | abnormal body length | BMP2 MFSD2A NEK1 USP42 RPS6KA3 PLXNA4 AUTS2 RREB1 CDH11 UNC80 SON | 6.50e-06 | 550 | 54 | 11 | MP:0001256 |
| Domain | - | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 3.20e-06 | 679 | 76 | 13 | 3.30.160.60 |
| Domain | zf-C2H2 | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 4.00e-06 | 693 | 76 | 13 | PF00096 |
| Domain | Znf_C2H2/integrase_DNA-bd | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 4.06e-06 | 694 | 76 | 13 | IPR013087 |
| Domain | ZINC_FINGER_C2H2_2 | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 1.33e-05 | 775 | 76 | 13 | PS50157 |
| Domain | ZINC_FINGER_C2H2_1 | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 1.37e-05 | 777 | 76 | 13 | PS00028 |
| Domain | Znf_C2H2-like | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 1.77e-05 | 796 | 76 | 13 | IPR015880 |
| Domain | Znf_C2H2 | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 1.99e-05 | 805 | 76 | 13 | IPR007087 |
| Domain | ZnF_C2H2 | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 2.07e-05 | 808 | 76 | 13 | SM00355 |
| Domain | zf-C2H2_6 | 2.88e-04 | 314 | 76 | 7 | PF13912 | |
| Domain | DUF1220 | 5.77e-04 | 9 | 76 | 2 | SM01148 | |
| Domain | NBPF_dom | 8.78e-04 | 11 | 76 | 2 | IPR010630 | |
| Domain | NBPF | 8.78e-04 | 11 | 76 | 2 | PS51316 | |
| Domain | DUF1220 | 8.78e-04 | 11 | 76 | 2 | PF06758 | |
| Domain | Cadherin_CS | 9.98e-03 | 109 | 76 | 3 | IPR020894 | |
| Domain | CADHERIN_1 | 1.10e-02 | 113 | 76 | 3 | PS00232 | |
| Domain | Cadherin | 1.10e-02 | 113 | 76 | 3 | PF00028 | |
| Domain | CADHERIN_2 | 1.13e-02 | 114 | 76 | 3 | PS50268 | |
| Domain | - | 1.13e-02 | 114 | 76 | 3 | 2.60.40.60 | |
| Domain | - | 1.15e-02 | 333 | 76 | 5 | 2.130.10.10 | |
| Domain | CA | 1.15e-02 | 115 | 76 | 3 | SM00112 | |
| Pubmed | The STUbL RNF4 regulates protein group SUMOylation by targeting the SUMO conjugation machinery. | PPP1R8 ZNF16 ZNF320 MLEC USP42 PHF3 ZNF316 ZNF189 AUTS2 WDR18 PODXL2 FASTKD2 NDUFB3 RPL10 EFTUD2 | 7.54e-08 | 1203 | 79 | 15 | 29180619 |
| Pubmed | XRN2 HIVEP2 ZNF234 ANK3 MLEC COPA AKAP17A AP2B1 MIB1 ZNF189 MAST1 EXOC7 PRRC2A ALPL CEP63 | 1.76e-07 | 1285 | 79 | 15 | 35914814 | |
| Pubmed | GRAMD1B XRN2 CAD MLEC COPA AP2B1 RPS6KA3 BCKDK WDR18 MCM2 PUM3 EXOC7 PRRC2A ALPL EFTUD2 | 7.46e-07 | 1440 | 79 | 15 | 30833792 | |
| Pubmed | MECP2 directly interacts with RNA polymerase II to modulate transcription in human neurons. | XRN2 CAD ERP44 COPA AKAP17A AP2B1 USP42 BCKDK WDR18 PODXL2 RPL10 SON EFTUD2 | 9.38e-07 | 1082 | 79 | 13 | 38697112 |
| Pubmed | Comprehensive identification of phosphorylation sites in postsynaptic density preparations. | 1.01e-06 | 231 | 79 | 7 | 16452087 | |
| Pubmed | The E3 ubiquitin ligase HECTD1 contributes to cell proliferation through an effect on mitosis. | XRN2 COPA AKAP17A PHF3 BCKDK WDR18 PUM3 EXOC7 PRRC2A RPL10 SON | 1.17e-06 | 759 | 79 | 11 | 35915203 |
| Pubmed | 1.84e-06 | 11 | 79 | 3 | 21364421 | ||
| Pubmed | 2.16e-06 | 503 | 79 | 9 | 16964243 | ||
| Pubmed | 2.29e-06 | 653 | 79 | 10 | 22586326 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 21898123 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 26014385 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 33007689 | ||
| Pubmed | LRRK2 phosphorylates novel tau epitopes and promotes tauopathy. | 5.09e-06 | 2 | 79 | 2 | 24113872 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 18992725 | ||
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 36198882 | ||
| Pubmed | MAPT IVS1+124 C>G modifies risk of LRRK2 G2385R for Parkinson's disease in Chinese individuals. | 5.09e-06 | 2 | 79 | 2 | 24559644 | |
| Pubmed | 5.09e-06 | 2 | 79 | 2 | 27932058 | ||
| Pubmed | USP49 potently stabilizes APOBEC3G protein by removing ubiquitin and inhibits HIV-1 replication. | 5.09e-06 | 2 | 79 | 2 | 31397674 | |
| Pubmed | BAP1 regulation of the key adaptor protein NCoR1 is critical for γ-globin gene repression. | XRN2 CAD COPA AKAP17A USP42 RPS6KA3 MIB1 MCM2 FASTKD2 RREB1 RPL10 SON EFTUD2 | 8.08e-06 | 1318 | 79 | 13 | 30463901 |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.02e-05 | 774 | 79 | 10 | 15302935 | |
| Pubmed | 1.46e-05 | 21 | 79 | 3 | 16079250 | ||
| Pubmed | 1.46e-05 | 638 | 79 | 9 | 33239621 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 23507417 | ||
| Pubmed | Impaired glutamate transport in a mouse model of tau pathology in astrocytes. | 1.53e-05 | 3 | 79 | 2 | 16407562 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 22303461 | ||
| Pubmed | A family study of DRD3 rs6280, SLC1A2 rs3794087 and MAPT rs1052553 variants in essential tremor. | 1.53e-05 | 3 | 79 | 2 | 27456607 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25878102 | ||
| Pubmed | TDP-43 pathology in a patient carrying G2019S LRRK2 mutation and a novel p.Q124E MAPT. | 1.53e-05 | 3 | 79 | 2 | 23664753 | |
| Pubmed | LRRK2 Facilitates tau Phosphorylation through Strong Interaction with tau and cdk5. | 1.53e-05 | 3 | 79 | 2 | 26268594 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 21816655 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 24288199 | ||
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 27356871 | ||
| Pubmed | Lrrk promotes tau neurotoxicity through dysregulation of actin and mitochondrial dynamics. | 1.53e-05 | 3 | 79 | 2 | 30571694 | |
| Pubmed | 1.53e-05 | 3 | 79 | 2 | 25804954 | ||
| Pubmed | Mechanisms of LRRK2-dependent neurodegeneration: role of enzymatic activity and protein aggregation. | 1.53e-05 | 3 | 79 | 2 | 28202670 | |
| Pubmed | SR protein kinases promote splicing of nonconsensus introns. | 1.87e-05 | 361 | 79 | 7 | 26167880 | |
| Pubmed | GRAMD1B CAD ANK3 COPA AP2B1 MAPT PLXNA4 MAST1 BSN NDUFB3 SLC1A2 PRRC2A RPL10 | 1.93e-05 | 1431 | 79 | 13 | 37142655 | |
| Pubmed | 2.03e-05 | 244 | 79 | 6 | 28902428 | ||
| Pubmed | 2.20e-05 | 847 | 79 | 10 | 35850772 | ||
| Pubmed | 2.50e-05 | 25 | 79 | 3 | 24947832 | ||
| Pubmed | 2.67e-05 | 689 | 79 | 9 | 36543142 | ||
| Pubmed | 2.90e-05 | 533 | 79 | 8 | 25544563 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 15252864 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 15383550 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 19527721 | ||
| Pubmed | 3.05e-05 | 4 | 79 | 2 | 24165324 | ||
| Pubmed | KAP1 facilitates reinstatement of heterochromatin after DNA replication. | 3.16e-05 | 704 | 79 | 9 | 29955894 | |
| Pubmed | Proteomic analysis identifies novel binding partners of BAP1. | 3.42e-05 | 80 | 79 | 4 | 34591877 | |
| Pubmed | Anticancer sulfonamides target splicing by inducing RBM39 degradation via recruitment to DCAF15. | 3.52e-05 | 714 | 79 | 9 | 28302793 | |
| Pubmed | 5.07e-05 | 5 | 79 | 2 | 36672770 | ||
| Pubmed | Neuronal delivery of Hedgehog directs spatial patterning of taste organ regeneration. | 5.07e-05 | 5 | 79 | 2 | 29279401 | |
| Pubmed | Metalloprotease SPRTN/DVC1 Orchestrates Replication-Coupled DNA-Protein Crosslink Repair. | 5.07e-05 | 5 | 79 | 2 | 27871366 | |
| Pubmed | 5.34e-05 | 32 | 79 | 3 | 14973295 | ||
| Pubmed | The Tumor Suppressor CIC Directly Regulates MAPK Pathway Genes via Histone Deacetylation. | 5.46e-05 | 583 | 79 | 8 | 29844126 | |
| Pubmed | Proteome-scale mapping of binding sites in the unstructured regions of the human proteome. | 5.67e-05 | 430 | 79 | 7 | 35044719 | |
| Pubmed | 5.86e-05 | 33 | 79 | 3 | 25064009 | ||
| Pubmed | Regulation of epidermal differentiation through KDF1-mediated deubiquitination of IKKα. | 6.12e-05 | 182 | 79 | 5 | 32239614 | |
| Pubmed | 6.19e-05 | 298 | 79 | 6 | 30737378 | ||
| Pubmed | Sonic hedgehog is not required for polarising activity in the Doublefoot mutant mouse limb bud. | 7.60e-05 | 6 | 79 | 2 | 9425131 | |
| Pubmed | Morphological evidence of the importance of epithelial tissue during mouse tongue development. | 7.60e-05 | 6 | 79 | 2 | 14567981 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 9546672 | ||
| Pubmed | Phosphorylation by neuronal cdc2-like protein kinase promotes dimerization of Tau protein in vitro. | 7.60e-05 | 6 | 79 | 2 | 9353289 | |
| Pubmed | 7.60e-05 | 6 | 79 | 2 | 24804200 | ||
| Pubmed | Genome-wide mapping of IBD segments in an Ashkenazi PD cohort identifies associated haplotypes. | 7.60e-05 | 6 | 79 | 2 | 24842889 | |
| Pubmed | MYC multimers shield stalled replication forks from RNA polymerase. | 8.07e-05 | 989 | 79 | 10 | 36424410 | |
| Pubmed | 8.07e-05 | 193 | 79 | 5 | 22589738 | ||
| Pubmed | 8.29e-05 | 37 | 79 | 3 | 7584028 | ||
| Pubmed | 8.29e-05 | 37 | 79 | 3 | 23266329 | ||
| Pubmed | 8.89e-05 | 197 | 79 | 5 | 21386911 | ||
| Pubmed | 8.99e-05 | 463 | 79 | 7 | 27503909 | ||
| Pubmed | Loss of ER retention motif of AGR2 can impact mTORC signaling and promote cancer metastasis. | 9.00e-05 | 807 | 79 | 9 | 30575818 | |
| Pubmed | Defining the human deubiquitinating enzyme interaction landscape. | USP49 HIVEP2 ERP44 COPA AP2B1 USP42 WDR18 MCM2 PRRC2A EFTUD2 | 9.21e-05 | 1005 | 79 | 10 | 19615732 |
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 11181841 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 20711177 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 18160010 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 19520069 | ||
| Pubmed | 1.06e-04 | 7 | 79 | 2 | 23190742 | ||
| Pubmed | Identifying biological pathways that underlie primordial short stature using network analysis. | 1.07e-04 | 1024 | 79 | 10 | 24711643 | |
| Pubmed | Identification of SUMO Binding Proteins Enriched after Covalent Photo-Cross-Linking. | 1.12e-04 | 332 | 79 | 6 | 32786267 | |
| Pubmed | 1.26e-04 | 844 | 79 | 9 | 25963833 | ||
| Pubmed | 1.30e-04 | 43 | 79 | 3 | 7584026 | ||
| Pubmed | 1.34e-04 | 494 | 79 | 7 | 26831064 | ||
| Pubmed | Noggin null allele mice exhibit a microform of holoprosencephaly. | 1.41e-04 | 8 | 79 | 2 | 21821669 | |
| Pubmed | Genetic utility of broadly defined bipolar schizoaffective disorder as a diagnostic concept. | 1.41e-04 | 8 | 79 | 2 | 19567891 | |
| Pubmed | Analysis of epithelial-mesenchymal interactions in the initial morphogenesis of the mammalian tooth. | 1.41e-04 | 8 | 79 | 2 | 9769173 | |
| Pubmed | 1.41e-04 | 8 | 79 | 2 | 11311121 | ||
| Pubmed | PTPN14 regulates Roquin2 stability by tyrosine dephosphorylation. | 1.55e-04 | 678 | 79 | 8 | 30209976 | |
| Pubmed | H4K20me0 recognition by BRCA1-BARD1 directs homologous recombination to sister chromatids. | XRN2 COPA USP42 PHF3 KLF5 ZFP64 WDR18 RREB1 RPL10 SON EFTUD2 | 1.61e-04 | 1294 | 79 | 11 | 30804502 |
| Pubmed | Phosphorylation of human microtubule-associated protein tau by protein kinases of the AGC subfamily. | 1.82e-04 | 9 | 79 | 2 | 17512525 | |
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 32344102 | ||
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 23423383 | ||
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 31199918 | ||
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 17397822 | ||
| Pubmed | Evidence for an expansion-based temporal Shh gradient in specifying vertebrate digit identities. | 1.82e-04 | 9 | 79 | 2 | 15315763 | |
| Pubmed | 1.82e-04 | 9 | 79 | 2 | 26671463 | ||
| Pubmed | 1.83e-04 | 230 | 79 | 5 | 29513927 | ||
| Pubmed | An organelle-specific protein landscape identifies novel diseases and molecular mechanisms. | PPP1R8 NEK1 XRN2 GPBP1L1 ANK3 MLEC AP2B1 MCM2 RREB1 EXOC7 EFTUD2 | 1.93e-04 | 1321 | 79 | 11 | 27173435 |
| Pubmed | 1.95e-04 | 233 | 79 | 5 | 37704626 | ||
| Pubmed | 2.04e-04 | 529 | 79 | 7 | 14621295 | ||
| Pubmed | 2.17e-04 | 51 | 79 | 3 | 24510904 | ||
| Interaction | AP2A2 interactions | 1.20e-05 | 199 | 78 | 7 | int:AP2A2 | |
| Interaction | MRPS35 interactions | 2.46e-05 | 307 | 78 | 8 | int:MRPS35 | |
| Interaction | MRPS31 interactions | 2.64e-05 | 310 | 78 | 8 | int:MRPS31 | |
| Interaction | STIP1 interactions | USP49 XRN2 CAD COPA AP2B1 MAPT RPS6KA3 BCKDK LRRK2 WDR18 MCM2 RPL10 SON EFTUD2 | 2.81e-05 | 1006 | 78 | 14 | int:STIP1 |
| Interaction | ARHGEF7 interactions | 2.84e-05 | 153 | 78 | 6 | int:ARHGEF7 | |
| Interaction | CNOT6L interactions | 3.04e-05 | 93 | 78 | 5 | int:CNOT6L | |
| Interaction | MRPS34 interactions | 3.09e-05 | 317 | 78 | 8 | int:MRPS34 | |
| Interaction | YWHAZ interactions | GRAMD1B NEK1 CAD GPBP1L1 HIVEP2 ERP44 SASH1 AP2B1 MAPT PHF3 LRRK2 MAST1 MCM2 PUM3 PRRC2A EFTUD2 | 3.74e-05 | 1319 | 78 | 16 | int:YWHAZ |
| Interaction | YTHDF3 interactions | 4.69e-05 | 246 | 78 | 7 | int:YTHDF3 | |
| Interaction | LRRK1 interactions | 4.74e-05 | 102 | 78 | 5 | int:LRRK1 | |
| Interaction | NPM1 interactions | ZNF16 HIVEP2 ANK3 MAPT GLI1 RPS6KA3 WDR18 MCM2 PUM3 SPRTN PRRC2A RPL10 SON EFTUD2 CEP63 | 4.89e-05 | 1201 | 78 | 15 | int:NPM1 |
| Interaction | UFD1 interactions | 5.13e-05 | 170 | 78 | 6 | int:UFD1 | |
| Interaction | HDAC6 interactions | FAT1 XRN2 CAD COPA AP2B1 MAPT GLI1 LRRK2 APOBEC3G MCM2 RPL10 ALPL EFTUD2 | 5.33e-05 | 929 | 78 | 13 | int:HDAC6 |
| Interaction | CTNND1 interactions | 7.49e-05 | 265 | 78 | 7 | int:CTNND1 | |
| Interaction | RNF4 interactions | PPP1R8 ZNF16 ZNF320 MLEC AKAP17A USP42 PHF3 ZNF316 ZNF189 AUTS2 WDR18 PODXL2 FASTKD2 NDUFB3 RPL10 EFTUD2 | 8.43e-05 | 1412 | 78 | 16 | int:RNF4 |
| Interaction | ILF2 interactions | 9.01e-05 | 590 | 78 | 10 | int:ILF2 | |
| Interaction | SRPK2 interactions | SLC39A12 XRN2 ZNF234 ANK3 AKAP17A MAPT PUM3 PRRC2A ALPL SON EFTUD2 | 9.51e-05 | 717 | 78 | 11 | int:SRPK2 |
| Interaction | HECTD1 interactions | XRN2 MLEC COPA AKAP17A PHF3 BCKDK WDR18 PUM3 EXOC7 PRRC2A RPL10 SON EFTUD2 | 9.54e-05 | 984 | 78 | 13 | int:HECTD1 |
| Interaction | FAM98B interactions | 1.03e-04 | 120 | 78 | 5 | int:FAM98B | |
| Interaction | TNRC6B interactions | 1.10e-04 | 282 | 78 | 7 | int:TNRC6B | |
| Interaction | RPL5 interactions | 1.12e-04 | 606 | 78 | 10 | int:RPL5 | |
| Interaction | HDAC2 interactions | PPP1R8 CAD GPBP1L1 COPA AP2B1 GLI1 KLF5 RPS6KA3 RREB1 RPL10 ALPL EFTUD2 | 1.16e-04 | 865 | 78 | 12 | int:HDAC2 |
| Interaction | CTNNB1 interactions | USP49 CAD FAM193A ANK3 COPA MAPT KLF5 LRRK2 MAST1 MCM2 CDH11 RPL10 EFTUD2 | 1.23e-04 | 1009 | 78 | 13 | int:CTNNB1 |
| Interaction | MRTO4 interactions | 1.26e-04 | 200 | 78 | 6 | int:MRTO4 | |
| Interaction | DHX58 interactions | 1.36e-04 | 26 | 78 | 3 | int:DHX58 | |
| Interaction | MRPL15 interactions | 1.82e-04 | 214 | 78 | 6 | int:MRPL15 | |
| Interaction | MRPS18B interactions | 1.86e-04 | 307 | 78 | 7 | int:MRPS18B | |
| Interaction | MRPL39 interactions | 1.91e-04 | 216 | 78 | 6 | int:MRPL39 | |
| Interaction | EPS15L1 interactions | 1.98e-04 | 138 | 78 | 5 | int:EPS15L1 | |
| Interaction | MRPS14 interactions | 2.11e-04 | 220 | 78 | 6 | int:MRPS14 | |
| Interaction | UBR5 interactions | 2.13e-04 | 533 | 78 | 9 | int:UBR5 | |
| Interaction | SHMT2 interactions | PPP1R8 XRN2 ERP44 COPA WDR18 PUM3 FASTKD2 SPRTN EXOC7 EFTUD2 | 2.56e-04 | 671 | 78 | 10 | int:SHMT2 |
| Interaction | FYN interactions | 2.60e-04 | 431 | 78 | 8 | int:FYN | |
| Interaction | CSNK2A1 interactions | GRAMD1B PPP1R8 XRN2 AKAP17A MAPT RPS6KA3 AUTS2 MAST1 MCM2 ACE RPL10 EFTUD2 | 2.92e-04 | 956 | 78 | 12 | int:CSNK2A1 |
| Interaction | YWHAE interactions | NEK1 CAD GPBP1L1 HIVEP2 SASH1 COPA MAPT LRRK2 MAST1 MCM2 FASTKD2 SPRTN PRRC2A EFTUD2 | 2.97e-04 | 1256 | 78 | 14 | int:YWHAE |
| Interaction | HSP90AB1 interactions | ANK3 MAPT GLI1 RPS6KA3 BCKDK MYO3B LRRK2 MAST1 MCM2 SPRTN PRRC2A EFTUD2 | 3.04e-04 | 960 | 78 | 12 | int:HSP90AB1 |
| Interaction | MRPS27 interactions | 3.05e-04 | 333 | 78 | 7 | int:MRPS27 | |
| Interaction | RPS17 interactions | 3.28e-04 | 337 | 78 | 7 | int:RPS17 | |
| Interaction | HSPH1 interactions | 3.37e-04 | 448 | 78 | 8 | int:HSPH1 | |
| Cytoband | 1p13.3 | 2.37e-04 | 69 | 79 | 3 | 1p13.3 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr19q13 | 1.03e-03 | 1192 | 79 | 8 | chr19q13 | |
| Cytoband | Ensembl 112 genes in cytogenetic band chr7p22 | 1.64e-03 | 134 | 79 | 3 | chr7p22 | |
| GeneFamily | Zinc fingers C2H2-type|ZF class homeoboxes and pseudogenes | ZNF16 ZNF320 HIVEP2 ZNF234 ZSCAN1 GLI1 KLF5 ZFP41 ZFP64 ZNF316 ZNF189 RREB1 ZNF649 | 5.05e-07 | 718 | 60 | 13 | 28 |
| GeneFamily | Neuroblastoma breakpoint family | 5.87e-05 | 23 | 60 | 3 | 662 | |
| Coexpression | GRYDER_PAX3FOXO1_TOP_ENHANCERS | 6.51e-06 | 441 | 78 | 9 | M172 | |
| Coexpression | GSE3920_UNTREATED_VS_IFNG_TREATED_ENDOTHELIAL_CELL_DN | 1.86e-05 | 184 | 78 | 6 | M6696 | |
| Coexpression | ZHONG_PFC_C3_ASTROCYTE | 2.08e-05 | 389 | 78 | 8 | M39102 | |
| Coexpression | GSE5099_CLASSICAL_M1_VS_ALTERNATIVE_M2_MACROPHAGE_UP | 2.51e-05 | 194 | 78 | 6 | M6595 | |
| Coexpression | GSE3982_CTRL_VS_LPS_4H_MAC_DN | 2.90e-05 | 199 | 78 | 6 | M5368 | |
| Coexpression | GSE16450_CTRL_VS_IFNA_6H_STIM_IMMATURE_NEURON_CELL_LINE_UP | 2.98e-05 | 200 | 78 | 6 | M7417 | |
| Coexpression | GRYDER_PAX3FOXO1_ENHANCERS_IN_TADS | MFSD2A FAT1 SASH1 COPA KLF5 AUTS2 MCM2 PODXL2 C1GALT1 FASTKD2 B4GALNT3 CDC42EP3 | 4.14e-05 | 1009 | 78 | 12 | M157 |
| Coexpression | HEVNER_CORTICAL_PLATE_POSTMITOTIC_NEURONS | 5.44e-05 | 136 | 78 | 5 | MM407 | |
| Coexpression | WELCSH_BRCA1_TARGETS_DN | 6.46e-05 | 141 | 78 | 5 | M2428 | |
| ToppCell | COPD-Epithelial-ATII|World / Disease state, Lineage and Cell class | 9.06e-07 | 183 | 79 | 6 | 8e9aab4eeec2e282c2cab9bfca6dbf40d660c7b9 | |
| ToppCell | COPD-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 1.03e-06 | 187 | 79 | 6 | 030af361f8bdcd0aff4ec1922702833325cf74d8 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D175|Adult / Lineage, Cell type, age group and donor | 1.06e-06 | 188 | 79 | 6 | ec38def1fdbb34ed9b30244806975bd5a4370164 | |
| ToppCell | BALF-PFMC-Severe-critical_progression_d12-22_with-steroid-Lymphocytic-Lymphocytic_T-mature_alpha-beta_T_cell-T_CD4_c03-ITGA4|Severe-critical_progression_d12-22_with-steroid / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.13e-06 | 190 | 79 | 6 | 91ba66d4b56c59523485b17738e93f14bb00afa4 | |
| ToppCell | normal_Lung-Epithelial_cells-AT2|normal_Lung / Location, Cell class and cell subclass | 1.24e-06 | 193 | 79 | 6 | 80ad1bdc50ecb8a50362f718248441cae20904a6 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-Gamma_Delta_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.35e-06 | 196 | 79 | 6 | 6eabbac1625f715531bae562a28da27664572600 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-1|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-06 | 198 | 79 | 6 | 19eefd05573fbaed654af52bf0f8a26092b8b229 | |
| ToppCell | distal-1-Epithelial-Alveolar_Epithelial_Type_2|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.43e-06 | 198 | 79 | 6 | ce9d6b2a93c7b304414ce1b8b1a09562cf581278 | |
| ToppCell | ASK428-Epithelial-Type_2|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 1.43e-06 | 198 | 79 | 6 | ec0d1801363adb70c6a26655b79d12b438c7417d | |
| ToppCell | distal-1-Epithelial|1 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.48e-06 | 199 | 79 | 6 | 9086dbb60863c3da2cc5d0a310f28596a01c52ca | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.48e-06 | 199 | 79 | 6 | a38a981cffa61c8444a980916de7414e689a1b63 | |
| ToppCell | distal-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.48e-06 | 199 | 79 | 6 | 21b44031bc5182ee23ba5e206042b2e5e4ee0c3c | |
| ToppCell | distal-3-Epithelial-Signaling_Alveolar_Epithelial_Type_2|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 79 | 6 | a77087a393aad674d4aa457ca6c0077b0424053d | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 200 | 79 | 6 | 3c251ad03fbbdae91dfd9037880ba43adbb03807 | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 79 | 6 | f47bb79202a59404e4916993a1f59cffcf710320 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-06 | 200 | 79 | 6 | c2bde99b3bc7a8740441c1a0c1394892b940b857 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial-AT2-2|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-06 | 200 | 79 | 6 | c905451425d1c24773bb0ca69bcf0309b277d2f1 | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | 23088edc62bf7d4db890937bfd7925dc316fcc76 | |
| ToppCell | Lung_Parenchyma-Control-Epithelial-Epithelial|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-06 | 200 | 79 | 6 | 3ff9abd5e07780a59d5571da906fa15f00a1d5c2 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2|Severe / Location, Disease Group, Cell group, Cell class (2021.03.09) | 1.52e-06 | 200 | 79 | 6 | acc771a902cf2f060c3eb9aedb72a256f5778a6c | |
| ToppCell | Parenchymal-10x5prime-Epithelial-Epi_alveolar|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | b2d61bc3afac0d78aa30082760da5b1a15d1fad2 | |
| ToppCell | Parenchyma_COVID-19-Epithelial-TX-AT2-2|Parenchyma_COVID-19 / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | ceb613ac6cdf0e3e6bb3f04d89034e18a524cefb | |
| ToppCell | distal-Epithelial-Signaling_Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 79 | 6 | b0e5c8b425f47833cdc00b5aa3734c8c980f0967 | |
| ToppCell | Bronchial-10x5prime-Epithelial-Epi_alveolar-AT2|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 1.52e-06 | 200 | 79 | 6 | b535323e18d9fb0dde1e0026df142c831e48c29f | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX-AT2-2|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | 35c05cae30cd6b323d2662f1396ddeab08bc75fc | |
| ToppCell | Fetal_brain-organoid_Tanaka_cellReport-GW26-Neuronal-Cortical_neuron|GW26 / Sample Type, Dataset, Time_group, and Cell type. | 1.52e-06 | 200 | 79 | 6 | 5b3df61ff421846ef4cabf1bd5355534c8b95509 | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 1.52e-06 | 200 | 79 | 6 | 95b9cc2d6f18d8c3ece933e5537c16e1b7137b34 | |
| ToppCell | Parenchyma_Control_(B.)-Epithelial-TX|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 1.52e-06 | 200 | 79 | 6 | 9970e9bde6aa2ff3aef60dcb065ff15b7463e147 | |
| ToppCell | Lung_Parenchyma-Severe-Epithelial-Epithelial-AT2-2-|Severe / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 1.52e-06 | 200 | 79 | 6 | eb44d1f80ecaac3a022cd04ab16dc36151e45488 | |
| ToppCell | E16.5-samps-Mesenchymal-Matrix_fibroblast-_fetal-matrix_-_immature_3|E16.5-samps / Age Group, Lineage, Cell class and subclass | 6.89e-06 | 149 | 79 | 5 | 651494e84be03dc7b061ebdfa91756a1c507b9b4 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-06 | 160 | 79 | 5 | 731def6d82814ebac1a400bc7aea5f6da43ec960 | |
| ToppCell | 390C-Epithelial_cells-Epithelial-A_(AT2)-|390C / Donor, Lineage, Cell class and subclass (all cells) | 9.74e-06 | 160 | 79 | 5 | cf27b4ac4d0caa6f9b068dc8ea93472470a01a4d | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_1/2_(AT1/AT2-like)|Adult / Lineage, Cell type, age group and donor | 1.07e-05 | 163 | 79 | 5 | e819a1d6d28290854aa0672b3a18fa9e293d8f23 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 164 | 79 | 5 | b0ed8cb6000ce8bf94444307e4b7b3574fa3fab2 | |
| ToppCell | 367C-Epithelial_cells-Epithelial-A_(AT2)-|Epithelial_cells / Donor, Lineage, Cell class and subclass (all cells) | 1.10e-05 | 164 | 79 | 5 | 3aea6207a011ad55a1aeb2ed9fb54d31b23694b5 | |
| ToppCell | saliva-Severe-critical_progression_d12-22_no-steroids-Myeloid-Granulocytic-Neutrophil-Neu_c5-GSTP1(high)OASL(low)|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k) | 1.31e-05 | 170 | 79 | 5 | 07b561cd9c528bc8444c9385e1de621eee7b697e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 177 | 79 | 5 | 9c7c6824b9011363851f084a500d665f025b026e | |
| ToppCell | facs-Kidney-nan-24m-Epithelial-kidney_collecting_duct_epithelial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.59e-05 | 177 | 79 | 5 | 2bf639e9e801e5144462ffc957f5739e0dfcd500 | |
| ToppCell | Control-Epithelial_cells-AT2|Control / group, cell type (main and fine annotations) | 1.72e-05 | 180 | 79 | 5 | 198b19e7910b4a8cc7e820c525ab357c7f99f578 | |
| ToppCell | 21-Trachea-Mesenchymal-Mesenchyme_SERPINF1-high|Trachea / Age, Tissue, Lineage and Cell class | 1.81e-05 | 182 | 79 | 5 | 354dcdb01360597f68c4fe157a682aee1c0b8bb1 | |
| ToppCell | COVID-19-Epithelial_cells-AT2|COVID-19 / group, cell type (main and fine annotations) | 1.91e-05 | 184 | 79 | 5 | 369b82f793deab672204558ae4e112cfa5aa9ccc | |
| ToppCell | IPF-Epithelial-ATII|IPF / Disease state, Lineage and Cell class | 1.96e-05 | 185 | 79 | 5 | 563b4e6d92bb5d77a3829556116a8e99aebac615 | |
| ToppCell | IPF-Epithelial-ATII|World / Disease state, Lineage and Cell class | 2.01e-05 | 186 | 79 | 5 | 6a4ff2da0af0f5e590d9f9daa5b5e9ac8c868947 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.01e-05 | 186 | 79 | 5 | acfa68a2afb7d2b51c9b469a1965fe5cc5d5e64e | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.1.3|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.07e-05 | 187 | 79 | 5 | 7c44cec1c26ca5907a495f2d7e633410e2e9728f | |
| ToppCell | COPD-Epithelial-ATII|COPD / Disease state, Lineage and Cell class | 2.12e-05 | 188 | 79 | 5 | eb6d79d733b53f64ca615bb777c64ed456866549 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D231|Adult / Lineage, Cell type, age group and donor | 2.17e-05 | 189 | 79 | 5 | dab54a52358f66a8a9460cd6089a06c5fa7e7a5d | |
| ToppCell | Control-Epithelial-ATII|Control / Disease state, Lineage and Cell class | 2.23e-05 | 190 | 79 | 5 | d50902a3abcc18aafa36d83cc2c6e07d7f7cb197 | |
| ToppCell | Fetal_29-31_weeks-Epithelial-alveolar_epithelial_cell_type_2-D150|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.29e-05 | 191 | 79 | 5 | 34cc997e4e5c727495f321e6807a84aa124da486 | |
| ToppCell | 367C-Epithelial_cells|367C / Donor, Lineage, Cell class and subclass (all cells) | 2.29e-05 | 191 | 79 | 5 | d31975fc33779b0b3ff1a50d7c64fec8d08be4d4 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.29e-05 | 191 | 79 | 5 | 2b0d55a8e1b4ce862dd038f8e0429e8428fb8aba | |
| ToppCell | COVID-19-lung-AT2|lung / Disease (COVID-19 only), tissue and cell type | 2.29e-05 | 191 | 79 | 5 | 276455a64c2c3503d5048615762eb2ee37f0ac70 | |
| ToppCell | Children_(3_yrs)-Epithelial|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.29e-05 | 191 | 79 | 5 | e432c6e1ae82dddf84314ce73d2b7a991630d905 | |
| ToppCell | Epithelial|World / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 79 | 5 | 499e8893afea5e6d3371e0bd018f7e86a524d669 | |
| ToppCell | Epithelial-alveolar_epithelial_cell_type_2|World / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 79 | 5 | 58c3737be7acce39fd2b91d70d6d7b2bbaa4f710 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 79 | 5 | cc9911e182a289779a2612bc213daae5607689e7 | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2-D122|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 79 | 5 | 06013a07e3a873b1d1c0451643c528593ac32a9c | |
| ToppCell | Adult-Epithelial|Adult / Lineage, Cell type, age group and donor | 2.34e-05 | 192 | 79 | 5 | efb962a5fd3b9bdfd8cf8d13c435e29c8271713e | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 79 | 5 | fd4d3c0d7caf8a2fff5b3d901fc28d19a8163cdf | |
| ToppCell | Adult-Epithelial-alveolar_epithelial_cell_type_2|Adult / Lineage, Cell type, age group and donor | 2.40e-05 | 193 | 79 | 5 | 738f4f0a9ddde2432b429ab46838e353b1790589 | |
| ToppCell | AT2_cells-Donor_02|World / lung cells shred on cell class, cell subclass, sample id | 2.40e-05 | 193 | 79 | 5 | 8187f976fd2d11fad3286690f1a046e894772220 | |
| ToppCell | nucseq-Epithelial-Epithelial_Alveolar-AT2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.40e-05 | 193 | 79 | 5 | f3cc7cfdbc164a4ed42f87647111522b7d393bcb | |
| ToppCell | (1)_Osterolineage_cells|World / Cell class and subclass of bone marrow stroma cells in homeostatis | 2.40e-05 | 193 | 79 | 5 | 035eeea9f77c4bf9cd85f07fa791b6c857be76b5 | |
| ToppCell | Children_(3_yrs)-Epithelial-alveolar_epithelial_cell_type_2-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.46e-05 | 194 | 79 | 5 | 97534c8bba895a7913665e03ae4e5c4a6ad71daf | |
| ToppCell | Control-Epithelial-ATII|Epithelial / Disease state, Lineage and Cell class | 2.46e-05 | 194 | 79 | 5 | a01de094f7bfd099bcbb2f94224690a2efb887b4 | |
| ToppCell | normal_Lung-Epithelial_cells-AT2|Epithelial_cells / Location, Cell class and cell subclass | 2.52e-05 | 195 | 79 | 5 | 81e13fe337f1d0a83d0deb86a0df797d306cd24d | |
| ToppCell | normal_Lung-Epithelial_cells|normal_Lung / Location, Cell class and cell subclass | 2.52e-05 | 195 | 79 | 5 | 7c90d887afde5c4d63352b5171be9987e2dfca58 | |
| ToppCell | Control-Epithelial|Control / Disease state, Lineage and Cell class | 2.52e-05 | 195 | 79 | 5 | 1798c3b89b1b5ff4f5777d2b9f52dc81cdad28fa | |
| ToppCell | renal_papilla_nuclei-Hypertensive_with+without-CKD-Epithelial-Collecting_tubule_epithelial_cell|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 2.52e-05 | 195 | 79 | 5 | 3d6d3de8ada6dce3dc789c15b50cc066e7100496 | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 196 | 79 | 5 | 7e5addaa844e66f8160e05858c341866a80aed23 | |
| ToppCell | ASK440-Epithelial-Type_2|ASK440 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.59e-05 | 196 | 79 | 5 | 754b4202b617165c6994a0b5a9b1e486dccdd44d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.4.1|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 196 | 79 | 5 | 988a3e0688e0a7ba69774497d3b130631bb26c50 | |
| ToppCell | LAM-Epithelial-AT2|LAM / Condition, Lineage and Cell class | 2.59e-05 | 196 | 79 | 5 | 9165041ef3d56b4d069497fee03dd1c6e273211d | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.0.0|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.59e-05 | 196 | 79 | 5 | fa42a8f8a11645fc733ce9c59c2a0599ecf2176d | |
| ToppCell | LAM-Epithelial|LAM / Condition, Lineage and Cell class | 2.65e-05 | 197 | 79 | 5 | e5cf07061f6d9db7f12ac17209b267373fa2270b | |
| ToppCell | 3'-Parenchyma_lung-Epithelial-Alveolar_epithelium-type_II_pneumocyte-AT2-AT2_L.0.1.3.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.65e-05 | 197 | 79 | 5 | bf10727fbe90b71d2ac60a11711e5f0701b3799d | |
| ToppCell | medial-2-Epithelial-Alveolar_Epithelial_Type_2|2 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | 102a4cbb138adbfba11ed955420095daa098532f | |
| ToppCell | AT2_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.72e-05 | 198 | 79 | 5 | 92c569c3b8a9fca2d4682cbf77ee8149bcc0a80a | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2-2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | 7caeed2d5dc78866023c8f38edcec9886baa9f2c | |
| ToppCell | distal-3|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | 3ee0bd36a01765dca9318a6c9b9be4898f7d56fa | |
| ToppCell | distal-Epithelial-Alveolar_Epithelial_Type_2-2|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | de5748c2b66ecc432974cf095ecd241369579f7c | |
| ToppCell | Parenchymal-NucSeq-Epithelial-Epi_alveolar-AT2|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 2.72e-05 | 198 | 79 | 5 | 2e2a4e1756bba6f4fbe529559a97d2993c890b4b | |
| ToppCell | medial-Epithelial-Alveolar_Epithelial_Type_2|medial / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.72e-05 | 198 | 79 | 5 | 53e5d76831d70b9a476f3ef3a81e13eda974d543 | |
| ToppCell | Biopsy_Other_PF-Epithelial-AT2|Biopsy_Other_PF / Sample group, Lineage and Cell type | 2.78e-05 | 199 | 79 | 5 | 9a65acfe9bf500db72142469cf17bf0973540001 | |
| ToppCell | Epithelial_cells|World / lung cells shred on cell class, cell subclass, sample id | 2.78e-05 | 199 | 79 | 5 | bbe69e44b7970f57628365ae771790f2b13d0cae | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal-6|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 1b1bccf4293f11048709d15a3c892c0edf3da3d2 | |
| ToppCell | ASK428-Epithelial|ASK428 / Donor, Lineage and Cell class of Lung cells from Dropseq | 2.78e-05 | 199 | 79 | 5 | ba2aaaeb4d9b448a6b9660b152fcac1a0e3fcfe7 | |
| ToppCell | Biopsy_Control_(H.)-Epithelial-AT2|Biopsy_Control_(H.) / Sample group, Lineage and Cell type | 2.78e-05 | 199 | 79 | 5 | 5323d49d3be980605b3e609b7f03bddba6e50e8a | |
| ToppCell | Neuron|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 1f8104fd92f04690b41d9d07ac08dc59d76bb97d | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.78e-05 | 199 | 79 | 5 | e459d5aa63c83f960562be33cea8182b0556eabf | |
| ToppCell | Neuron-Postmitotic|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 1973527f8a7d4c6490d75c0d0ea153688166a08b | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_-Parietal_and_Temporal|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 4bee94c116c0da5eba951cb4cea7cc9dcdd6e30f | |
| ToppCell | Transplant_Alveoli_and_parenchyma-Epithelial-Type_2_alveolar|Transplant_Alveoli_and_parenchyma / Tissue, Lineage and Cell class of Lung Cells from 10X | 2.78e-05 | 199 | 79 | 5 | e28ace2ca680c6154398e17110aa1838dd7a5548 | |
| ToppCell | Neuron-Postmitotic-Excitatory_Neuron_|World / Primary Cells by Cluster | 2.78e-05 | 199 | 79 | 5 | 058373b4ac3cec2108cb24265628ff0a50646e33 | |
| ToppCell | proximal-Epithelial-Signaling_Alveolar_Epithelial_Type_2-3|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-05 | 200 | 79 | 5 | 7bd76884fcffdbd9b8d24f5b6b5187ad3963da5f | |
| ToppCell | 10x_5'_v1-Non-neoplastic|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 2.85e-05 | 200 | 79 | 5 | 88e94b067da1068b2ff1f95c730f2a49c66d7fe6 | |
| ToppCell | cellseq-Epithelial|cellseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 2.85e-05 | 200 | 79 | 5 | e4204c4b864346f47d76b0f0faae96f04fed5082 | |
| ToppCell | distal-Epithelial|distal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-05 | 200 | 79 | 5 | 0a97080f694738bb882787cee21b91a4d5757b7a | |
| ToppCell | proximal-Epithelial|proximal / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-05 | 200 | 79 | 5 | 3790dd13c4ff471e716e5a2950f196e3c386dbb1 | |
| ToppCell | proximal-3-Epithelial|3 / Location, Lineage, Cell class (ontology) and Donor from 10X sequencing (macrophage renamed) | 2.85e-05 | 200 | 79 | 5 | 08858bb20630849ffb2192631e23466c242a1078 | |
| Disease | nephrotic syndrome (implicated_via_orthology) | 3.07e-05 | 24 | 75 | 3 | DOID:1184 (implicated_via_orthology) | |
| Disease | Progeria | 6.34e-05 | 5 | 75 | 2 | C0033300 | |
| Disease | microcephaly (implicated_via_orthology) | 7.42e-05 | 32 | 75 | 3 | DOID:10907 (implicated_via_orthology) | |
| Disease | Attached earlobe | 1.77e-04 | 8 | 75 | 2 | HP_0009907 | |
| Disease | schizophrenia (is_marker_for) | 1.94e-04 | 44 | 75 | 3 | DOID:5419 (is_marker_for) | |
| Disease | autoimmune thyroid disease | 3.05e-04 | 126 | 75 | 4 | EFO_0006812 | |
| Disease | Liver carcinoma | 3.07e-04 | 507 | 75 | 7 | C2239176 | |
| Disease | Abnormality of refraction | 3.09e-04 | 673 | 75 | 8 | HP_0000539 | |
| Disease | outer ear morphology trait | 4.14e-04 | 12 | 75 | 2 | EFO_0007664 | |
| Disease | Alzheimer's disease (implicated_via_orthology) | 4.18e-04 | 57 | 75 | 3 | DOID:10652 (implicated_via_orthology) | |
| Disease | juvenile polyposis syndrome (implicated_via_orthology) | 4.88e-04 | 13 | 75 | 2 | DOID:0050787 (implicated_via_orthology) | |
| Disease | advanced glycosylation end product-specific receptor, soluble measurement | 4.88e-04 | 13 | 75 | 2 | EFO_0020131 | |
| Disease | intermediate coronary syndrome (is_marker_for) | 4.88e-04 | 13 | 75 | 2 | DOID:8805 (is_marker_for) | |
| Disease | lobe size | 5.69e-04 | 14 | 75 | 2 | EFO_0007666 | |
| Disease | neutrophil count | IFIH1 SLC39A12 HIVEP2 COPA TAGAP MAPT KLF5 ZNF316 PCDHA13 NBPF6 RREB1 | 7.12e-04 | 1382 | 75 | 11 | EFO_0004833 |
| Disease | autosomal recessive polycystic kidney disease (implicated_via_orthology) | 7.48e-04 | 16 | 75 | 2 | DOID:0110861 (implicated_via_orthology) | |
| Disease | Parkinson's disease (is_implicated_in) | 9.70e-04 | 76 | 75 | 3 | DOID:14330 (is_implicated_in) | |
| Disease | type 1 diabetes mellitus (is_implicated_in) | 1.34e-03 | 85 | 75 | 3 | DOID:9744 (is_implicated_in) | |
| Disease | Autosomal Recessive Primary Microcephaly | 1.42e-03 | 22 | 75 | 2 | C3711387 | |
| Disease | Parkinson disease | 1.42e-03 | 22 | 75 | 2 | cv:C0030567 | |
| Disease | Ovarian Serous Adenocarcinoma | 1.56e-03 | 23 | 75 | 2 | C1335177 | |
| Disease | Albuminuria | 1.70e-03 | 24 | 75 | 2 | C0001925 | |
| Disease | chronotype measurement | 1.78e-03 | 882 | 75 | 8 | EFO_0008328 | |
| Disease | Depressive Symptoms | 1.99e-03 | 26 | 75 | 2 | C0086132 | |
| Disease | Thyroid preparation use measurement | 2.30e-03 | 217 | 75 | 4 | EFO_0009933 | |
| Disease | Autosomal Dominant Parkinsonism | 2.31e-03 | 28 | 75 | 2 | C0752098 | |
| Disease | Autosomal Dominant Juvenile Parkinson Disease | 2.31e-03 | 28 | 75 | 2 | C0752097 | |
| Disease | Parkinsonism, Experimental | 2.31e-03 | 28 | 75 | 2 | C0752101 | |
| Disease | Autosomal Recessive Parkinsonism | 2.31e-03 | 28 | 75 | 2 | C0752100 | |
| Disease | Familial Juvenile Parkinsonism | 2.31e-03 | 28 | 75 | 2 | C0752104 | |
| Disease | Ramsay Hunt Paralysis Syndrome | 2.31e-03 | 28 | 75 | 2 | C0242423 | |
| Disease | PARKINSON DISEASE 2, AUTOSOMAL RECESSIVE JUVENILE | 2.31e-03 | 28 | 75 | 2 | C1868675 | |
| Disease | sleep duration | 2.31e-03 | 362 | 75 | 5 | EFO_0005271 | |
| Disease | amyotrophic lateral sclerosis (is_marker_for) | 2.48e-03 | 29 | 75 | 2 | DOID:332 (is_marker_for) | |
| Disease | Amyotrophic Lateral Sclerosis With Dementia | 2.48e-03 | 29 | 75 | 2 | C0393554 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| FVEGSHGIHRKHLPI | 581 | P63010 | |
| HSHGPQFGSEVELRH | 1291 | P12821 | |
| HIHFPAGVIDAIRKH | 881 | Q6L9W6 | |
| APHKHGFLEGRHAEL | 246 | Q9HC16 | |
| HHLALHEDKPDFVGI | 206 | O14874 | |
| TFGHDGKGHPLHKRE | 266 | P12643 | |
| GDFRHTIHIGKEGQH | 36 | Q9UKI2 | |
| VFHGISKEDHRHSAP | 646 | P78312 | |
| PTDEDVGHRIKHVAG | 586 | Q3KR37 | |
| GHEHGHHKMELPDYR | 6 | O43676 | |
| GHRLAEHLVHKLSPE | 151 | Q96M43 | |
| GKDGELHIAEHPAGH | 541 | Q15397 | |
| GSHVRHHPSNKEEEG | 681 | P49736 | |
| PHAGDVEGHLSFLEK | 331 | P06727 | |
| LVEEVLPRHGSGHHG | 416 | Q9NZ53 | |
| KEHHEHFQIGPLGEI | 2121 | Q14517 | |
| EGDPARGEFHLHIEA | 86 | O60500 | |
| AAGHHHFPDADDIRK | 491 | Q96PY6 | |
| FEKHGEHLPRGEGRF | 26 | Q9HC44 | |
| DVHGIHFRKDPLEGR | 61 | Q14165 | |
| AITHHVKEGHEKADP | 51 | P51812 | |
| HDEGGPGRHASAKEH | 3631 | Q9UPA5 | |
| EIHHRKPHGPEAALE | 916 | Q13191 | |
| DEQADKHGIHDPHVR | 1721 | Q9HCM2 | |
| AKEGHLPEKDGHGHE | 911 | Q8WXX7 | |
| EKIGDEDGHFPAHRE | 386 | Q5S007 | |
| VHGPDAHVTKRHRGD | 386 | P08151 | |
| ISPGHEHDFRVKHLS | 326 | Q9UPT5 | |
| SLEVGHPDFRKDFHG | 1286 | Q9Y2H9 | |
| HPDFRKDFHGELALH | 1291 | Q9Y2H9 | |
| DKDGDTPLHEALRHH | 696 | Q86YT6 | |
| DAPHHRLLVLVKDHG | 641 | Q9Y5I0 | |
| DVIDDFHLKQPHFHG | 421 | Q8NA29 | |
| VEGGRIDHGHHEGKA | 331 | P05186 | |
| EFKPTHGQHRHDGIK | 556 | Q96MT8 | |
| KFDEHDGPVRGIDFH | 46 | P53621 | |
| SHLGSEEPKHRHLGL | 21 | P43004 | |
| AHHLIGAGHSSEFKP | 751 | Q9BYX4 | |
| LRPSFHGHHEKGKEG | 31 | P55287 | |
| HDVRENHIGHPESKS | 2876 | Q12955 | |
| LHSGKLHREFHHGPD | 351 | Q9BS26 | |
| IGKETFHPFVPEHHL | 261 | Q9NS00 | |
| HAEEILEKHPRGGSF | 121 | P54852 | |
| GLHKQEAPEFGHFHE | 426 | Q504Y0 | |
| EAPEFGHFHESKGHI | 431 | Q504Y0 | |
| THGTFLGHIRLEPHK | 91 | Q12972 | |
| HHVEDSRHRGSKEPL | 641 | Q8N103 | |
| GHRLAEHLVHKLSPE | 151 | Q86XG9 | |
| GHRLAEHLVHKLSPE | 151 | Q5VWK0 | |
| GKDGFHIRVRLHPFH | 81 | P27635 | |
| LGGEGHFSKDVHLPH | 586 | Q9NYY8 | |
| DELEGPDSKLHHGHD | 216 | P48634 | |
| KHLLGAEHGDEPRHG | 341 | Q9BV38 | |
| HLLPGHRSQDHKVGD | 101 | P23327 | |
| EDEKRAIGHDHKGHP | 136 | P20062 | |
| KPDDSHTHDELGVAH | 446 | Q02040 | |
| HQRIHTGERPHKCGE | 306 | O75820 | |
| PFHGGREHERAGLHE | 1076 | Q9H9J4 | |
| DHIRHQRVHTGEKPF | 101 | Q8N8Y5 | |
| HRRIHTGEKPHKCGD | 431 | A2RRD8 | |
| EDRERKGSIPFHHTG | 451 | Q8N2C7 | |
| EHGRGESHEPEEEHG | 1326 | Q92766 | |
| HFIEHQKTHREEGPF | 306 | Q8NBB4 | |
| GDVLFVGKHHPLHDF | 681 | Q9H0D6 | |
| EDHALKHFEETGHPL | 51 | Q70CQ1 | |
| SHVKEELEHPGVEHF | 641 | Q92576 | |
| TPLEGHRKGHEFEGT | 946 | O94885 | |
| HRKGHEFEGTHHPLG | 951 | O94885 | |
| EDTEGGRHAPELLKH | 176 | P10636 | |
| HVHLREPGGTHKEDF | 1471 | P27708 | |
| DREGHGPEFCKHMHR | 126 | Q9H040 | |
| SVGHHPFKHDVFLLE | 46 | Q14588 | |
| HLAAHVRGHTGEKPF | 761 | A6NFI3 | |
| KHHRTHTGEKPFECG | 366 | P17020 | |
| GDHDDDHPGMEVVLH | 46 | Q15029 | |
| GHENLSHGHTERFDP | 746 | P31629 | |
| DLDRHLRIHTGDKPH | 316 | Q9NTW7 | |
| ALHSGEEPHAEEHLK | 1506 | P18583 | |
| LLVHDSGPDHRKHFL | 2391 | P18583 | |
| EHEGEFTCHARHPLG | 401 | A6NMB1 | |
| LTEHERAHRGEKPHG | 221 | Q9BS31 | |
| FPGEELKHAHHRPQA | 46 | Q13887 | |
| HLLDHPFIKGVHGKV | 286 | Q8WXR4 |